Rheumatology Flashcards
1
Q
Rheumatoid arthritis - general
- Which cells target normal tissue
- Higher risk if do what
- Classic presentation
- Symptom onset - time frame
- X-ray findings (4)
- Blood protein in 70%
- Highly specific antibody
- Other bloods
A
- T cells
- Smoke
- Symmetrical swollen/painful/stiff small joints, worse in morning, long duration (>6 weeks)
- Over weeks/months
- Soft tissue swelling, loss of joint space, joint deformity, juxta-articular osteopaenia
- Rheumatoid factor - associated with more severe
- Anti-CCP
- Normo/microcytic anaemia, high platelets/ESR/CRP
2
Q
Rheumatoid arthritis - management
- Assess disease activity with
- General management - 1st line (+ monitoring)
- Others
- Side effects
- TNF-inhibitors if
- Hydroxychloroquine - what must be checked regularly
- Flare - 1st line
- Analgesia - most useful
A
- DAS28 + CRP monitoring
- DMARD monotherapy - methotrexate* (LFT, FBC)
- Sulfasalazine, hydroxychloroquine,
- GI upset, raised liver enzymes, bone marrow suppression, oral ulcers, pneumonitis
- 2 DMARDs didn’t work
- Retinal damage
- IM methylprednisolone
- NSAIDs
3
Q
Rheumatoid arthritis - examination
- Joints affected
- Typical distribution
- Joint - pathological processes (4)
- Boutonniere deformity =
- Swan neck deformity =
- Other hand/wrist signs
- Extra-articular manifestations - nodule location (6)
- Lungs (4)
- Cardiovascular
- Other
- Felty syndrome - 2 additional features
A
- Small-medium (MCP, PIP, wrist, MTP)
- Symmetrical
- Tenosynovitis, bursitis, thickened capsule, bone erosion, cartilage destruction
- PIP flexion, DIP hyperextension
- MCP flexion, PIP hyperextension, DIP flexion
- Ulnar deviation, wrist/finger subluxation (radiocarpal), ulnar claw (MCP extension, PIP flexion)
- Elbows, lungs, cardiac, CNS, lymphadenopathy, vasculitis
- Pleural disease, interstitial fibrosis, bronchiolitis obliterans, organising pneumonia
- IHD, pericarditis, pericardial effusion
- Anaemia, carpal tunnel, peripheral neuropathy, splenomegaly
- RA with splenomegaly + leukopaenia
4
Q
Spondyloarthropathies - general
- Types (4)
- Common features
- Enthesitis - definition, examples (3)
- Pathology - step 1
- Pathology - step 2
- Enteric arthropathy - associations
- Management
- Psoriatic arthritis - joint patterns (5)
- Examination
- Radiology
- Management
- Other HLA-B27-associated disease
A
- Ankylosing spondylitis, enteric arthropathy, psoriatic arthritis, reactive arthritis
- Seronegative (RhF -), HLA B27 associated, ‘axial’, asymmetrical, large joint, mono/oligo pattern, dactylitis
- Inflammation at insertion of a tendon, ligament or capsule in a bone (plantar fasciitis, achilles tendonitis, chostrochondritis)
- Initial inflammation + erosions
- Fibrosis + ossification
- IBD, GI bypass, Whipple’s disease, coeliac disease
- Arthropathy improves if treat bowel, DMARD if resistant
- Symmetrical poly, DIP only, asymmetrical oligo, spinal, mutilans
- Nail changes, dactylitis, aceneiform rash, palmo-plantar pustulosis
- Erosive, ‘pencil in cup’ if severe,
- NSAIDs, sulfasalazine, methotrexate
- Acute anterior uveitis
5
Q
Ankylosing spondylitis
- Classic patient
- Main joints affected (2)
- Extra-skeletal features
- Associated diseases
- Examination
- Diagnosis
- Imaging findings
- Bloods
- Management
A
- Young male - back pain worse at night with early morning stiffness >30 minutes (relieved by exercise)
- Spine, sacroiliac
- Apical fibrosis, anterior uveitis, aortic regurgitation, AV node block achilles tendonitis, amyloidosis, cauda equina, peripheral arthritis (25%, commoner if female)
- Crohn’s/UC
- Progressive loss of spine ROM in all directions, reduced thoracic expansion, sometimes progress to kyphosis + neck hyperextension
- MRI spine + sacroiliac joints
- MRI - marrow oedema (active inflammation), destructive changes (sclerosis, erosions, anklyosis).
CXR can also show sacroiliac joint space narrow/wider, T11-L1 syndesmophytes, causing fusion - Normocytic anaemia, high ESR/CRP
- NSAIDs, TNF inhibitors, exercise (physio imput)
6
Q
Osteoarthritis
- Risk factors
- Secondary predisposing factors (3)
- Classic joint presentation (4)
- Classic history
- Common joints (4)
- Examination - general
- Bouchards nodes - location
- Herberdens nodes - location
- X-ray changes (4)
- Bone screen - 3 components
- Management
A
- Age, obesity, female, occupation, muscle weakness, gout
- Trauma, congenital/developmental, metabolic disease
- Pain/crepitus, stiffness, swelling, deformity
- Pain/crepitus worse on moving, background ache at rest, stiffness post-rest, perceived power loss from pain
- Knee, hip, DIP + thumb CMC
- Joint tenderness, derangement, bony swelling, mild sinovitis, reduced ROM
- PIPJs
- DIPJs
- Loss of joint space, osteophytes, subchondral sclerosis, subchondral cysts
- ALP, Ca2+, phosphate
- Exercise, weight loss, analgesia (regular paracetamol + topical NSAIDs, short course PO + codeine if not enough), hot/cold packs, physio, joint replacement
7
Q
Methotrexate - counselling
- Action
- Timeline
- How to take
- Length of treatment
- Effects - time before
- Tests (+ when)
- Important side effects
- Complications (+ symptoms)
- Contraindications
- Supplementary advice - when to get help
- What else to do to avoid infection
- Avoid/limit what
- When not to take
- IMPORTANT LIFESTYLE ADVICE
A
- Disease modifier, reduced inflammation, improves symptoms
- Once weekly with folic acid at another time
- Tablet usually, sometimes injection
- Long-term
- 4-6 months
- FBC, U+E, LFT (at start, then every 2 weeks until stable, then every 3 months)
- Alopecia, headaches, GI upset (mucosal damage)
- Myelosuppression (infection, anaemia, unexplained bleed/bruise), hypersensitive (hepatitis/pneumonitis/rash)
- Trying for baby (M/F), pregnant, active infection, liver / renal failure, breastfeeding, immunodeficiency.
- Go to ED if myelosuppression or respiratory signs
- Get pneumococcal vaccine before + yearly flu jab
- Limit careful alcohol, no NSAIDs / aspirin / penicillin
- If have infection
- Contraception (M+F) whilst using + 3 months after
8
Q
Vasculitis - general
- Classified using what
- Can be primary, or secondary to what (6)
- General symptoms/test result
- Large vessel - types (3)
- Polymyalgia rheumatica -features
- Investigations
- Differentials (4)
- Management
- Takayasu arteritis - classic presentation
- Other signs
- Association
- Management
A
- Modified Chapel Hill Criteria
- SLE, RA, Hep B/C, HIV, malignancy
- Overwhelming fatigue, raised ESR/CRP, maybe ANCA
- Giant cell, polymyalgia rheumatica, takayasu arteritis
- > 50, F, subacute onset of fatigue, bilateral aching, tenderness, morning stiffness in shoulders, hips, proximal limbs, weight loss, anorexia, depression. Associated mild polyarthritis, tenosynovitis, carpal tunnel. NO weakness.
- CRP up, ESR >40/normal, ALP up in 30%, CK normal
- RA, polymyositis, hypothyroidism, cervical spondylosis
- Prednisolone 15mg PO (much better within 7 days)
- Female, asian, aorta occlusion, absent limb pulse
- Intermittent claudication, malaise, headache, carotid bruit
- Renal artery stenosis
- High dose prednisolone
9
Q
Medium vessel vasculitis - general
- Types (2)
- PAN - what is it
- Associated with what
- Features
- Commonest cause of death
- Diagnostic
- Management
- Kawasaki disease - features (6)
- Management
- Complications
A
- Polyarteritis nodosa (PAN), kawasaki disease
- Necrotising vasculitis, thrombosis/aneurysms
- Hep B, middle-aged men
- Fever, malaise, arthralgia, haematuria, renal failure
- Renal artery stenosis, glomerular ischaemia, HTN
- Renal/mesenteric angiography, renal biopsy
- Control BP, steroids if mild, steroid-sparing if severe
- High fever >5 days, conjunctival injection, cracked lips, strawberry tongue, cervical lymphadenopathy, red palms/soles of feet (peel)
- High dose aspirin, IVIG, echo
- Coronary artery aneurysm
10
Q
Small vessel vasculitis - general
- Types (3)
- Which associated with c-ANCA (targets PR3)
- Which associated with p-ANCA (targets MPO)
- Microscopic - signs
- eGPA (Churg-Strauss) - other features
- GPA (Wegener’s) - other features
- Management - to go into remission
- What to add if vital organ/life-threatening
- Maintenance therapy
A
- Eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, microscopic polyangitis
- GPA, sometimes microscopic
- EGPA, microscopic polyangitis
- Rapidly progressing glomerulonephritis, pulmonary haemorrhage
- Asthma, sinusitis, mononeuritis multiplex, p-ANCA
- URT (epistaxis, sinusitis, nasal crusting), LRT (dyspnoea, haemoptysis), vasculitis rash, eyes involved, pauci-immune glomerulonephritis, c-ANCA
- IV cyclophosphamide/ rituximab, glucocorticoid
- Plasma exchange
- Methotrexate / azathioprine / rituximab, + taper glucocorticoids
11
Q
High-dose steroids
- Things to check before starting
A
- GI protection, bone protection, screen for DM, monitor BP/weight
12
Q
Antiphospholipid syndrome
- Associated with (20-30%)
- Characteristics - ‘CLOTS’
- Main antibodies (2)
- Management
A
- SLE
- Coagulation defect (arterial/venous)
Livedo reticularis
Obstetric (recurrent miscarriage)
Thrombocytopaenia (cerebral, renal) - Anti-phospholipid (lupus anticoagulant, cardiolipin)
- Anticoagulation, pregnancy counselling
13
Q
Systemic lupus erythematosus (SLE)
- Autoantibody production against
- Drugs that induce (3)
- Type of arthritis
- Dermatological features (4)
- Cardiovascular features (3)
- Non-infective endocarditis - type, valve affected
- Respiratory features (3)
- Haematological features (4)
- Commonest cause of lupus-related death
- Main serological test
- Antibodies present
- Other bloods
- Management - mild
- Moderate
- Severe
A
- Nuclear material (ANA, homogenous)
- Minocycline, oral contraceptive, hydralazine
- Non-erosive
- Photosensitivity, butterfly rash, hair loss, mucosal ulceration
- Pericarditis, myocarditis, raynaud phenomenon
- Libman-sacks endocarditis, mitral valve
- Pleurisy, pleural effusions, pneumonitis
- Lymphopaenia, neutropaenia, anaemia, antiphosphalipid syndrome
- Glomerulonephritis
- ANA (95%)
- anti-dsDNA (60%), RF (40%), ENA in 20% (Ro, La, Sm, RNP), antiphospholipid (cardiolipin/Lupus anticoagulant)
- Low complement (C3/4/50), positive direct coombs
- NSAIDS / hydroxychloroquinine
- Corticosteroids / azathiprine / methotrexate
- Corticosteroids + cyclophosphamide / tacrolimus
14
Q
Sjogren’s syndrome
- Which glands affected, consequence
- Cause
- Commoner in
- Increased risk of
- Features
- Name for dry eyes
- Associated renal disease
- Type of neuropathy
- Investigations - what present in nearly all patients
- What positive in 70%
- What positive in 30%
- Test to measure tear formation
- Histology
- Other bloods - significant results (2)
A
- Exocrine, so dry mucosal surfaces
- Primary, or secondary to RA/other CTDs
- Women
- Lymphoid malignancy
- Dryness (eyes, mouth, vagina), joints (arthralgia, raynaud’s, myalgia,
- Keratoconjunctivitis sicca
- Renal tubular acidosis
- Sensory polyneuropathy
- Rheumatoid factor
- ANA, Anti-Ro (if primary)
- Anti-La
- Schirmer’s test: filter paper near conjunctival sac
- Focal lymphocytic infiltration
- Hypergammaglobulinaemia, low C4
15
Q
Raynaud’s syndrome
- Management - 1st line
A
- Nifedipine
16
Q
Fibromyalgia
- Risk factors (3)
- Associated symptoms (7)
- Investigations to rule out other diseases
- Diagnostic requirements
- Main pharmalogical treatment
- What not to use
- Chronic fatigue syndrome (myalgic encephalomyelitis)
- definition
A
- Female, middle age, stress
- Depression, fatigue, poor concentration, sleep disturbance, headache, paraesthesia, anxiety
- TSH, vit D, B12, iron studies, magnesium, ESR/ CRP
- Chronic (> 3 months), widespread (L/R, upper/lower)
- Amitriptyline
- NSAIDs
- Persistent disabling fatigue >6 months, present >50% of the time + 4 of: myalgia, polyarthralgia, worse memory, unrefreshing sleep, exertional fatigue >24 hours, sore throat, tender lymph nodes
17
Q
Gout
- Type of crystals
- Deposited where (3)
- Symptoms/signs - ‘G O U T’
- Urate high - threshold
- Primary - causes
Secondary gout - Over-production of uric acid - causes (4)
- Under-excretion of uric acid - causes (4)
- Bloods (2)
- Aspiration - findings
- X-ray - early
- Late
A
- Urate
- Joints, kidneys, soft tissues
- Great toe (MTP), One joint, Uric acid raised, Tophi
- > 0.4 mmol/L
- Uricaemia inherited disorder, hypothyrodism
- Psoriasis, polycythaemia rubra vera, leukaemia, primary hyperparathyroidis, diet (alcohol, red meat, sweeteners\0
- HTN, renal disease, alcohol, elderly, diuretics
- Urate, U+Es
- Needle shaped crystals, negatively birefringent
- Soft tissue swelling
- Periarticular erosion + disruption, NORMAL joint space
18
Q
Pseudogout (CPPD)
- Risk factors (4)
- Joints affected
- Acute - pattern
- Chronic - pattern
- Aspiration - findings
- X-ray - finding
- Management - acute
- Prophylaxis
- Complications
A
- Arthritis, DM, hyperparathyroidism, haemochromatosis, low phosphate
- Knees, wrists, hips
- Large joint mononeuropathy post illness/surgery/trauma
- Inflammatory, symmetrical, polyarthritis/sinovitis
- Oval / rhomboid crystals, weakly positively birefringent
- Chondrocalcinosis (soft tissue calcium deposits)
- Usually self limiting, rest, NSAIDs, cool packs, intra-articular steroids
- NSAIDs (+ PPI) + colchicine
- Secondary osteoarthritis
19
Q
Gout - management
- Conservative
- Avoid what
- Acute flare
- Long-term prophylaxis - what
- Indication
- How long to wait before starting post-flare
- Titration
- Other indications (2)
- Side effects
- Give what alongside when starting
- What happens in next flare
- Alternative if contraindicated (+ side effect)
A
- Weight loss
- Purine rich food, alcohol excess, aspirin, diuretics
- NSAIDs / Colchicine / Steroids (if renal impairment so can’t have other two), rest/elevate, ice packs
- Allopurinol
- > 1 flare in 12 months, but especially if >2 flares, renal disease, uric acid renal stones, tophi
- Wait until inflammation reduced (3 weeks)
- 100mg a day, increase every 4 weeks until plasma urate < 0.3.
- Cytotoxics, diuretics
- Rash, fever, low WCC, can preciptate flare
- NSAID (6 weeks) / colchicine 0.5mg bd 6 months
- Don’t stop allopurinol
- Febuxostat (deranged LFTs)
20
Q
Antibodies/protein markers present
- Rheumatoid arthritis (2)
- SLE (5)
- Drug-induced SLE
- Sjogren’s (4)
- Anti-phospholipid syndrome (2)
- Polymyositis / dermatomyositis (2)
- Limited cutaneous systemic sclerosis
- Diffuse systemic sclerosis
- Which can cross placenta in pregnancy
A
- Rheumatoid factor, anti-CCP
- ANA (95%) anti-dsDNA (60%), RF (40%), ENA in 20% (Ro, La, Sm, RNP), antiphospholipid (cardiolipin/Lupus anticoagulant)
- Anti-histone
- ENA (Ro, La), ANA, rheumatoid factor, anti-CCP
- Anti-phospholipid (cardiolipin, lupus anticoagulant)
- Anti-Jo, ANA
- Anti-centromere, ANA
- Anti-Scl70
- Anti-Ro, anti-La
21
Q
Rheumatology history - general
- Screening questions (3)
- Presenting symptoms
- Extra-articular features
- Related diseases
- Current/past drugs
- Family history
- Social history
A
- Free from pain/stiffness in joints/muscle/back, dress self, walk up/down stairs
- Pattern, symmetry, morning stiffness >30 minutes, pain, swelling, loss of function, erythema, warmth
- Rash/photosensitivity, Raynaud’s, nodules/nodes, ulcers (mouth/genitals), dry eyes/mouth, anterior uveitis, diarrhoea/urethritis, weight loss
- Crohn’s/UC, preceding infections, psoriasis
- NSAIDs, DMARDs, biological agents
- Arthritis, psoriasis, autoimmune disease
- Age, occupation, sexual history, smoking (may worsen RA), home help
22
Q
Arthritides - differentials
- Monoarthritis (4)
- Oligoarthritis (5)
- Symmetrical polyarthritis (4)
- Asymmetrical polyarthritis (3)
A
- Septic, crystal, osteorthritis, trauma (haemarthrosis)
- Crystal, psoriatic, reactive, ankylosing spondylitis, osteoarthritis
- Rheumatoid, osteoarthritis, viruses (Hep A/B/C, mumps), systemic conditions
- Reactive, psoriatic, systemic
23
Q
Reactive arthritis
- Joint pattern
- Causative organisms (broad areas)
- Other clinical features
- Reiter’s syndrome - triad
- Investigations - investigate reactive cause
- Management
A
- Oligoarthritis, asymmetrical
- GI (salmonella, campylobacter, yersinia), GU (chlamydia)
- Iritis, keratoderma blenorrhagia (raised brown plaques on soles/palms), circinate balanitis (painless penile ulceration from chlamydia), mouth ulcers, enthesitis
- Arthritis, urethritis, conjunctivitis
- ESR, CRP, stool culture if diarrhoea, sexual health review, viral serology
- No specific cure; splint joints, NSAIDs, local steroid injections
24
Q
Synovial fluid (appearance, viscosity, WBC, neutrophils)
- Normal
- Osteoarthritis
- Haemorrhagic
- Rheumatoid arthritis
- Crystal arthritis (gout/CPPD)
- Septic arthritis
- Bloods - general
A
- Clear, normal V, WBC <200, neuts 0
- Clear/straw, high V, WBC <1000, neuts <50%
- Xanthochromic, varied V, WBC <10000, neuts <50%
- Turbid/yellow, low V, WBC 1-50,000, neuts varied
- Turbid/yellow, low V, WBC 5-50,000, neuts 80%
- Turbid/yellow, low V, WBC 10-100,000, neuts >90%
- FBC, ESR, urate, U+E, CRP, culture if ? septic
25
NSAIDs - side effects and how to manage
1. GI
Avoid concomitant prescription of
2. CV
NSAID with lowest CV risk
3. Renal
Higher risk if
4. Counselling - important points
1. Bleeding/ulcers/perforation; prescribe PPI if >45 or other bleeding risk
Anticoagulants, antiplatelets, SSRI, spironolactone, steroids, bisphosphonates
2. MI/stroke
Naproxen
3. Failure
Diuretics, ACE-i, ARBs, elderly, HTN, T2DM
4. Only take when need, stop + get help immediately if new abdominal pain / any signs of GI bleeding (black stool, fainting), no mixing NSAID types, smoking/alcohol increase risk
26
Systemic sclerosis
1. Features
2. Limited cutaneous (CREST) - location, association
3. Antibodies (2)
4. Diffuse - antibodies (2)
1. Scleroderma, internal organ fibrosis, microvascular abnormality
2. Face, hands, feet; subclinical pulmonary HTN (sildenafil)
3. ANA (anti-centromere)
4. Anti-SCL-70, anti-nucleolar, anti-CCP, anti-RNAP (20%)
27
Myositis
1. Definition
2. Polymyositis - definition
3. Associated muscular symptoms
4. Extra-muscular signs
5. Dermatomyositis - skin signs
6. Associated malignancies
7. Bloods
8. Diagnostic test
9. Other tests + findings (2)
10. Antibodies
11. Management - general
12. Skin
1. Autoimmune striated muscle inflammation
2. Insidious progressive symmetrical proximal muscle weakness
3. Myalgia, dysphagia, dyphonia, respiratory weakness
4. Fever, arthralgia, Raynaud's, interstitial lung fibrosis, myocarditis, aryythmias
5. Gottron's papules (rough/red, knuckle/elbow/knee), macular rash ('shawl sign' if on shoulders), eyelid heliotrope + oedema, nailfold erythema
6. Lung, pancreas, ovary, bowel
7. Raised muscle enzymes (e.g. CK, ALT, AST, LDH)
8. Muscle biopsy
9. EMG (fibrillation potentials), MRI (muscle oedema
10. Anti-Mi2, anti-Jo1
11. Prednisolone, immunosuppressant/cytotoxic if resistant
12. Hydroxychloroquine / topical tacrolimus
28
Vasculitis - variable vessel size
1. Behcet's syndrome - triad
2. Associated with which HLA
3. Classic patient
4. Other symptoms
5. Test suggestive of diagnosis
6. Cogan syndrome - inflamed where
7. Other features
1. Oral ulcers, genital ulcers, anterior uveitis
2. B51
3. Young middle eastern men, positive FH
4. Thrombophebitis, DVT, arthritis, aseptic meningitis, erythema nodosum, GI (abdominal pain, diarrhoea, colitis)
5. Positive pathergy test (puncture site following needle prick becomes inflamed with small pustule forming)
6. Cornea
7. Fever, fatigue, weight/hearing loss, vertigo, tinnitus
29
Systemic disease + skin - description, causes
1. Erythema nodosum
2. Erythema multiforme
3. Erythema migrans
4. Erythema marginatum
1. Painful, blue-red, raised, on shins. Sarcoid, drugs (sulphonamides, OCP), streptococcal infection, Crohn's
2. 'Target' lesions (symmetrical/central blister, on limbs, palms/soles. Stevens-Johnson syndrome post-drugs, or collagen disorder
3. Small papule at site of tick bite, forming large erythematous ring with central fading ('bullseye'). Lyme
4. Transient trunk pink coalescent rings. Rheumatic fever
30
Methotrexate - general (non-counselling)
1. Prevents which cellular function
2. Used in what (3)
3. Long-term use - complications (2)
1. Cellular replication
2. DMARD for RA, chemotherapy, severe psoriasis
3. Hepatic cirrhosis, pulmonary fibrosis
31
Juvenile idiopathic arthritis
1. Definition
2. Stills disease - features
3. Polyarticular - specific features
4. Pauci-articular (oligo) - specific features
1. Arthritis without any other cause, lasting more than 6 weeks in patients under the age of 16
2. Salmon-pink rash, swinging fever, lymphadenopathy, splenomegaly, joint pain, ANA/RF negative
3. 4+ joints, symmetrical, RF negative
4. <4, larger joints (but not hips), uveitis, positive ANA